Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis A Randomized Trial

Simple item page
dc.contributor.authorvan Zyl-Smit, Richard N.
dc.contributor.authorEsmail, Aliasgar
dc.contributor.authorBateman, Mary E.
dc.contributor.authorPau, Maria Grazia
dc.contributor.authorBenko, Jacqueline
dc.contributor.authorKagina, Benjamin M. N.
dc.date.accessioned2023-02-15T20:21:31Z
dc.date.available2023-02-15T20:21:31Z
dc.date.issued2017
dc.description.abstractAdministration of tuberculosis (TB) vaccines in participants with previous or current pulmonary TB may have the potential for causing harmful postvaccination immunologic (Koch-type) reactions. To assess the safety and immunogenicity of three dose levels of the AERAS-402 live, replication-deficient adenovirus 35–vectored TB candidate vaccine, containing three mycobacterial antigens, in individuals with current or previous pulmonary TB. We performed a phase II randomized, placebo-controlled, double-blinded dose-escalation study in an HIV-negative adult South African cohort (n = 72) with active pulmonary TB (on treatment for 1–4 mo) or pulmonary TB treated at least 12 months before study entry and considered cured. Safety endpoints included clinical assessment, flow volume curves, diffusing capacity of the lung for carbon monoxide, pulse oximetry, chest radiograph, and high-resolution thoracic computerized tomography scans. Cytokine expression by CD4 and CD8 T cells, after stimulation with Ag85A, Ag85B, and TB10.4 peptide pools, was examined by intracellular cytokine staining.en_US
dc.identifier.citationvan Zyl-Smit, R. N., Esmail, A., Bateman, M. E., Dawson, R., Goldin, J., van Rikxoort, E., ... & Bateman, E. D. (2017). Safety and immunogenicity of adenovirus 35 tuberculosis vaccine candidate in adults with active or previous tuberculosis. A randomized trial. American Journal of Respiratory and Critical Care Medicine, 195(9), 1171-1180.https://doi.org/10.1164/rccm.201603-0654OCen_US
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/7820
dc.language.isoenen_US
dc.publisherAmerican Journal of Respiratory and Critical Care Medicineen_US
dc.subjecttuberculosisen_US
dc.subjectTB vaccineen_US
dc.subjectvaccine immunogenicityen_US
dc.titleSafety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis A Randomized Trialen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.pdf
Size:
797.89 KB
Format:
Adobe Portable Document Format
Description:
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences